--- title: Sepranolone for PMS: what the clinical trials show description: Sepranolone for PMS hasn't been proven in trials. Here's what the research on PMDD shows, typical dosing, side effects, and what to try instead. url: https://niyora.com/treatments/sepranolone-for-pms/ --- - [Niyora](https://niyora.com/) - [Treatments](https://niyora.com/treatments/) - Sepranolone for PMS: does it work? Treatment # Sepranolone for PMS: does it work? Sepranolone hasn't been tested in PMS, only in PMDD, and the larger of two placebo-controlled trials didn't find a clear, consistent benefit over placebo. It's an investigational injection, not something a doctor can prescribe today. Other PMS treatments, like SSRIs taken only before your period or certain contraceptives, have stronger evidence behind them right now. Updated 14 October 2026 Niyora editorial Mixed evidence Strength of evidence Mixed Trials disagree, or the effect is small. - None - Limited - Mixed - Moderate - Strong ## At a glance - Sepranolone has only been tested in women with PMDD, never in PMS specifically, so the evidence doesn't apply directly. - The larger, more rigorous 2021 trial of 206 women didn't find a clear benefit over placebo. - It's given as a subcutaneous injection every 48 hours through the luteal phase in trials, not a pill a doctor can currently prescribe. - Side-effect data is limited because the trials focused mainly on symptom scores, not safety profiles. - SSRIs, certain hormonal contraceptives, and CBT have stronger evidence for PMS right now. ## Strength of evidence Mixed evidence - None - Limited - Mixed - Moderate - Strong Two placebo-controlled trials tested sepranolone in women with PMDD, not PMS. The larger 2021 trial (206 women) found no clear, consistent benefit over placebo, so it isn't an approved or reliable treatment for PMS today, even though the GABA-A theory behind it is still being studied. ## Does sepranolone work for PMS? Sepranolone hasn't been tested in women with PMS. Every published trial so far studied women with PMDD, the more severe diagnosis, so the evidence for PMS is borrowed rather than direct. Even for PMDD, the results are mixed. Across the two randomized, placebo-controlled trials run so far, one with 126 women and a larger one with 206, sepranolone didn't show a clear, consistent benefit over placebo [1] [2]. It remains an investigational drug, not something a pharmacy can dispense. **Sepranolone isn't a treatment to count on for PMS right now.** If you want something with firmer evidence behind it, [PMS treatment that actually helps](https://niyora.com/treatments/pms-treatment/) covers the options guidelines do recommend. If your pattern sounds more like PMDD, sepranolone for PMDD covers the same trials in that context, and [what is PMS](https://niyora.com/premenstrual-syndrome/) explains how the two differ. ## What does the research say? Sepranolone (also called UC1010) is a synthetic version of isoallopregnanolone, a steroid the body makes naturally. It's designed to block allopregnanolone, a byproduct of progesterone that acts on GABA-A receptors in the brain. The theory is that in sensitive women, rising allopregnanolone before a period worsens mood rather than calming it, which is what sepranolone was built to test [1]. Two trials have tested this idea in women with PMDD, both run across multiple European centers with daily symptom tracking (DRSP) used to confirm the diagnosis. | Trial | Design | Sepranolone dose | Main finding | | --- | --- | --- | --- | | 2017 phase II [1] | Randomized, double-blind, placebo-controlled, 1 cycle, 126 women | 10mg or 16mg, every 48 hours | Explorative result, used to set the dose for the larger trial | | 2021 phase II [2] | Randomized, double-blind, placebo-controlled, 3 cycles, 206 women | 10mg or 16mg, every 48 hours | Larger, longer trial didn't confirm a clear benefit over placebo | | No PMS trial | Not studied | Not applicable | Evidence for PMS is extrapolated from PMDD trials, not direct | The bigger, more rigorous trial is the one that carries the most weight, and its results are a big part of why sepranolone isn't an approved treatment today. What the research says The 2017 and 2021 studies are the two randomized, placebo-controlled trials of sepranolone we have data on, both in women with PMDD [1] [2]. ## How do you take sepranolone for PMS? There's no approved PMS dose, because sepranolone isn't an approved medication anywhere. What we know comes entirely from trial protocols in PMDD. In both trials, women received: - A subcutaneous injection (under the skin), not a pill - Either 10mg or 16mg of sepranolone - A dose every 48 hours through the luteal phase, the roughly 14 days before a period - Treatment for one cycle in the smaller 2017 trial, three cycles in the 2021 trial [1] [2] That's a research protocol, not a dosing guide you could follow at home, even if you could get hold of the drug. If sepranolone or a similar GABA-A modulating treatment is eventually approved, dosing will be set by the trials that get it there, and a doctor would be the one prescribing it. ## How long does it take to work, and what are the side effects? In the trials, women rated their symptoms daily on the DRSP scale through each treatment cycle, so researchers were looking for change within a single luteal phase, roughly two weeks of dosing [1] [2]. Because the larger trial didn't show a clear advantage over placebo, there's no reliable answer to how long sepranolone takes to help, since the evidence doesn't confirm that it reliably does. The published trials focused mainly on symptom scores rather than detailed safety reporting, so a full side-effect profile isn't well established in what's publicly available. What is clear: - It's given by injection, which has its own practical downsides, like injection-site reactions or needing to self-inject - Long-term safety hasn't been studied, since trials ran for one to three cycles - Safety during pregnancy or breastfeeding hasn't been established If you want a treatment with a clearer side-effect picture, SSRIs and certain hormonal contraceptives have been studied for far longer and have well-documented effects, covered in [PMS treatment that actually helps](https://niyora.com/treatments/pms-treatment/). ## Who should avoid it? Because sepranolone isn't approved or available by prescription, there's no official guidance yet on who should avoid it. The 2021 trial's exclusion criteria give a rough sense of where more caution would likely apply: - Women who were pregnant or breastfeeding - Women with an ongoing psychiatric disorder - Women taking medications that might interact with the study drug - Women without regular menstrual cycles [2] If a GABA-A modulating treatment like this is approved in the future, these exclusions suggest a doctor would weigh similar factors before prescribing it. For now, the more useful question is which [PMS treatment](https://niyora.com/treatments/pms-treatment/) you could actually start this cycle. ## What else helps alongside it? Since sepranolone isn't something you can get today, the more useful question is what to do this cycle. Guidelines point to treatments with much stronger evidence for PMS: - SSRIs, which some women take only in the luteal phase rather than every day - Certain hormonal contraceptives - Cognitive behavioral therapy (CBT) A doctor decides which of these fits your situation, especially around dose and timing. [PMS treatment that actually helps](https://niyora.com/treatments/pms-treatment/) walks through each option in more detail. While you wait on a plan, or in a hard moment this week, Niyora is a PMS and PMDD support app. Its Moon feature lets you write down what happened, see it from another angle, and draft a reply you can hold onto for 20 minutes before you send anything. If your symptoms take a week of every month or more, tracking them daily on a [DRSP chart](https://niyora.com/tools/drsp-chart/) for two cycles gives you and a doctor something concrete to look at. When to see a doctor If this takes a week of every month, or you have thoughts of hurting yourself, see a GP or gynecologist and bring two months of daily notes. If that pattern looks like it could be PMDD, finding a PMDD specialist is a good next step. ## Questions people ask Does sepranolone work for PMS? + No trial has tested sepranolone in PMS specifically, only in PMDD. In the largest trial so far, 206 women with PMDD in a 2021 Psychoneuroendocrinology study, sepranolone didn't show a clear benefit over placebo. Until that changes, PMS treatments with stronger evidence, like SSRIs or certain contraceptives, are the better bet. What is sepranolone, and how is it supposed to work? + Sepranolone is a synthetic version of isoallopregnanolone, a steroid that blocks allopregnanolone, a progesterone byproduct that acts on GABA-A receptors in the brain. The theory is that in sensitive women, rising allopregnanolone before a period worsens mood, and sepranolone counters that effect (2017 phase II trial, Psychoneuroendocrinology). How is sepranolone given, and at what dose? + In trials, sepranolone was given as a subcutaneous injection, not a pill, at 10mg or 16mg every 48 hours through the luteal phase, the roughly two weeks before a period. It's investigational, so there's no approved prescription dose available outside a research study. Can I get a sepranolone prescription for PMS right now? + No. Sepranolone hasn't been approved for PMS or PMDD anywhere, so no doctor can prescribe it outside a clinical trial. If you want proven options now, SSRIs taken in the luteal phase, some hormonal contraceptives, and CBT all have stronger evidence behind them for PMS. What side effects does sepranolone have? + Published trials focused mainly on symptom scores, so a detailed side-effect profile for sepranolone isn't well established. It's given by injection, which carries its own practical downsides, and its safety during pregnancy, breastfeeding, or long-term use hasn't been studied. ## Sources - 1. [Treatment of premenstrual dysphoric disorder with the GABA A receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial](https://doi.org/10.1016/j.psyneuen.2017.02.031), Psychoneuroendocrinology, 2017 - 2. [A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder](https://doi.org/10.1016/j.psyneuen.2021.105426), Psychoneuroendocrinology, 2021 Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗ On this page - [Does sepranolone work for PMS?](#does-sepranolone-work-for-pms) - [What does the research say?](#what-does-the-research-say) - [How do you take sepranolone for PMS?](#how-do-you-take-sepranolone-for-pms) - [How long does it take to work, and what are the side effects?](#how-long-does-it-take-to-work-and-what-are-the-side-effects) - [Who should avoid it?](#who-should-avoid-it) - [What else helps alongside it?](#what-else-helps-alongside-it) - [Questions](#faq) Niyora PMS & PMDD support For the hard moment before your period. Private, no account. [Get it on iPhone](https://apps.apple.com/app/niyora-pms-emotions/id6764561688) ## Keep reading Treatment PMS treatment: what actually helps Condition What is PMS? Premenstrual syndrome, explained Care guide Finding a PMDD specialist Guide All 26 research findings